---
$id: https://graph.org.ai/products/commodity/51361926
$type: Product
source: UNSPSC
code: "51361926"
title: "Barbital or barbitone"
class: "51361900"
classTitle: "Hypnotic barbiturates"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Barbital or barbitone

**UNSPSC Code**: 51361926
**Class**: [Hypnotic barbiturates](Hypnotic barbiturates.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a barbiturate with the molecular formula C8H12N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5WZ53ENE2P, chemically known as 2,4,6(1h,3h,5h)-pyrimidinetrione, 5,5-diethyl- (9ci) but generally known as barbital, which bears US NIH Compound Identifier 2294. Barbital most often comes in base, n-glucoside, and sodium forms. European Medicines Agency schedules Barbital in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06102MIG. The term BARBITAL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules barbital in its Anatomical Therapeutic Chemical (ATC) Classification. BARBITAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Barbital or barbitone bears US NLM identifiers UMLS ID C0004743 and NCI Concept Code C76526. SMILES: O=C1NC(=O)NC(=O)C1(CC)CC.

